Tenax Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Tenax Therapeutics

28/03/2024 21:02

* Tenax Therapeutics Inc  TENX.OQ  reported a quarterly
adjusted
loss of $12.98​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $-138.40.  The mean expectation of two analysts
for the quarter was for a loss of $8.14 per share. Wall Street
expected results to range from $-9.33 to $-6.96 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Tenax Therapeutics Inc's reported EPS for the quarter was
a loss
of $12.98​.
    * The company reported a quarterly loss of $3.23 million.
    * Tenax Therapeutics Inc shares had fallen by 82.4% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 13.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Tenax
Therapeutics Inc is $32.50 

This summary was machine generated from LSEG data March 28 at
09:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -8.14          -12.98         Missed
 Sep. 30 2023      -7.20          -6.40          Beat
 Jun. 30 2023      -8.00          -4.00          Beat
 Mar. 31 2023      -29.60         -12.00         Beat